3 Contact Hour(s)
Tuesday, May 14, 2019
Sunday, May 1, 2022
ACPE Expiration Date
Sunday, May 1, 2022
We live in an “Opioid Crisis” where someone dies approximately every 7 minutes from drug overdose. So just how do we end this “Opioid Crisis”, or at least, how do we as healthcare professionals contribute to the progress of society in the right direction? In this monograph, we will review overall pain management etiology; numerous non-pharmacological and pharmacological treatment options (with particular attention on opioid medications), opioid overdose reversal treatments; along with not only how to identify drug seeking and diversion behaviors, but possible actions to take when the behaviors are suspected. The West Virginia Controlled Substances Monitoring Program (CSMP) will of course also be discussed for its expected impact on adherence and diversion. We will also review West Virginia specific controlled substance laws and trends such as controlled substance classifications, prescribing authorities, the Opioid Reduction Act of 2018, the naloxone standing order, and DEA Red Flags. Unlike opioids, this monograph is intended to open one’s eyes, elevate blood pressure and/or heart rate, and increase cognition (in relation to the Opioid Crisis).
PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.
In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.
PharmD, MBA, BCGP, CPE
Assistant Professor, West Virginia University School of Pharmacy
This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).